Facebook
Twitter
LinkedIn
ForwardBreast Cancer Update 2018: Management and Treatment (RP1809C)
The Breast Program Leadership Committee wants to provide the opportunity to share new innovations in breast care to all staff. The multidisciplinary care at the Harold C. Simmons Comprehensive Cancer Center are organized by disease-oriented teams (DOT). Most staff members, including the breast DOT, may not be aware of the new technologies and treatment plans available for breast patients. The purpose of this educational event is to present new innovations in the disciplines of surgical oncology, medical oncology, radiation oncology, genetics, plastic surgery, and imaging.
Target Audience
This activity is intended for providers in the specialties of:
- Oncology (Medical)
- Pathology
- Plastic Surgery
- Radiology
- Surgery - Oncology
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the significance of breast cancer stage as an approximation of prognosis/survival.
- Identify molecular subtypes and their significance in the new integrated AJCC 8th edition staging manual.
- Explain the importance of regional lymph node staging using imaging techniques and the overall accuracy of each imaging modality.
- Review the imaging modalities available to help correctly determine the true extent of disease in women with dense tissue who have been recently diagnosed with breast cancer.
- Describe updated therapeutic guidelines as well as information regarding ongoing clinical trials regarding breast and axillary nodal surgery in breast cancer patients.
- To describe use of Gamma Pod partial breast irradiation, including patient selection, logistics of treatment and patient experience with this technique.
- Review current NCCN management recommendations for patients with breast cancer gene mutations.
- Identify new methods in Implant based reconstruction and techniques and outcomes
- Evaluate challenges in Implant based reconstruction.
- Review new trial data supporting the use and effectiveness of decrease chemotherapy and HER2 therapy in adjuvant treatment.
Time | Topic | Presenter |
06:30 – 07:00 | Registration, Continental breakfast Introductions | Dr. Phil Evans |
07:00-07:15 | A New Breast Cancer Staging Paradigm | Dr. Basak Dogan |
07:15-07:30 | Evaluating Extent of Disease in Women with Dense Breasts | Dr. Stephen Seiler |
07:30-07:45 | Less is More in Breast Cancer Surgery | Dr. Rachel Wooldridge |
07:45-08:00 | Systemic Breast Cancer Treatment: the drive to deceleration. | Dr. Barbara Haley |
08:00-08:15 | GammaPod – A New Innovation in Partial Breast Radiation Therapy | Dr. Ann Spangler |
08:15-08:30 | Update on Breast Cancer Gene Mutations | Caitlin Mauer |
08:30-08:45 | New Frontiers in Breast Reconstruction: Implant and Autologous reconstruction | Dr. Sumeet Teotia |
Wrap-Up | ||
08:45-09:00 | Discussion, Disclosures Evaluations, | Dr. Phil Evans |
Course Director:
W. Phil Evans, M.D., FACR, FSBI
Clinical Professor and Division Chief, Breast Imaging
George and Carol Poston Professorship in Breast Cancer Research
Director, UT Southwestern Center for Breast Care
Walter Evans, M.D.
Walter Evans, M.D.
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 2.00 AMA
- 2.00 Attendance